Menu Search
Equities

Avantor Inc

AVTR:NYQ

Avantor Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)20.36
  • Today's Change0.22 / 1.09%
  • Shares traded6.28m
  • 1 Year change+2.83%
  • Beta1.2975
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Avantor Inc's revenues fell -7.26% from 7.51bn to 6.97bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 686.50m to 321.10m, a -53.23% decrease.
Gross margin33.53%
Net profit margin4.54%
Operating margin9.13%
Return on assets2.42%
Return on equity5.81%
Return on investment2.75%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Avantor Inc fell by 109.20m. However, the company earned 870.00m from its operations for a Cash Flow Margin of 12.49%. In addition the company used 143.70m on investing activities and also paid 843.70m in financing cash flows.
Cash flow per share1.05
Price/Cash flow per share19.39
Book value per share8.16
Tangible book value per share-5.35
More ▼

Balance sheet in USDView more

Avantor Inc has a Debt to Total Capital ratio of 46.98%, a lower figure than the previous year's 103.75%.
Current ratio1.54
Quick ratio1.06
Total debt/total equity0.8862
Total debt/total capital0.4698
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.